The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
MFS Emerging Markets Debt I MEDIX
- NAV / 1-Day Return 11.95 / +0.31 %
- Total Assets 7.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.810%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Emerging Markets Bond
- Credit Quality / Interest Rate Sensitivity Low/Extensive
- Min. Initial Investment —
- Status Open
- TTM Yield 6.58%
- Effective Duration 6.61 years
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:16 PM GMT+0
Morningstar’s Analysis MEDIX
Will MEDIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Currency Cash CASH_USD | 8.30 | 586.0 Mil | Cash and Equivalents |
USD/EUR FWD 20240719 Purchased | 4.92 | 347.3 Mil | Derivative |
5 Year Treasury Note Future Sept 24 | 2.91 | 205.0 Mil | Government |
United States Treasury Notes 2.75% | 1.99 | 140.6 Mil | Government |
10 Year Treasury Note Future Sept 24 | 1.94 | 136.9 Mil | Government |
UST Bond 30Yr Future SEP 19 24 | 1.79 | 126.6 Mil | Government |
Ultra 10 Year US Treasury Note Future Sept 24 | 1.66 | 116.8 Mil | Government |
Oman (Sultanate Of) 6.75% | 1.37 | 96.9 Mil | Government |
Oman (Sultanate Of) 7% | 1.20 | 85.0 Mil | Government |
BRL/USD NDF 20240702 Purchased | 0.96 | 67.5 Mil | Derivative |